Teleflex issues Class I recall of pediatric anesthesia devices
Histogenics files for $65m IPO
Histogenics filed for an initial public offering, aiming to raise up to $65 million as it begins Phase III testing of its knee cartilage product NeoCart.
The regenerative medicine company plans to list its shares on the NASDAQ exchange under the symbol HSGX.
Medtronic launches Verify incontinence device in the U.S.
FDA OKs Integra Lifesciences Puerto Rico plant
Irish startup Embo Medical gets $3.8m in seed funding
Platinum fires back at Echo Therapeutics over ‘rogue’ directors
GI Dynamics shares plunge on EU sales halt for EndoBarrier device
Prostate cancer: FDA panel recommends against approval for SonaCare’s Sonablate
SonaCare Medical said it will reposition its Sonablate prostate cancer device to treat a more aggressive stage of the disease after an FDA panel last week failed to recommend approval for the device.
Stryker completes Small Bone Innovations buy
TAVI: Claret Medical launches U.S. trial
Claret Medical said today that the 1st patient has been treated in a U.S. pivotal trial of its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.